Literature DB >> 17223988

A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response.

Olga Giménez-Palop1, Gabriel Giménez-Pérez, Dídac Mauricio, José-Miguel González-Clemente, Neus Potau, Eugenio Berlanga, Roser Trallero, Blandine Laferrère, Assumpta Caixàs.   

Abstract

OBJECTIVE: Ghrelin and polipeptide YY (PYY) are involved in the regulation of food intake. We evaluated these two peptides and their possible relationship in adult patients with Prader-Willi syndrome (PWS). PATIENTS: Seven patients with PWS, 16 age-sex-BMI matched obese and 42 age-sex matched lean subjects. DESIGN AND MEASUREMENTS: Fasting plasma PYY and ghrelin levels were measured in all subjects and, postprandially until 6 h, in seven matched subjects of each group.
RESULTS: Fasting ghrelin levels were higher in PWS than in the other two groups. Fasting PYY levels were lower in patients with PWS than in lean subjects but similar to those in obese subjects. The postprandial decrease in ghrelin concentrations was lower in PWS as compared to the other two groups and therefore the 6-h-postprandial area under the curve (AUC) for ghrelin was higher in PWS than in obese subjects. PYY response after the meal was blunted in patients with PWS, but not in the other two groups that showed a peak at 60 min The AUC for PYY was lower in PWS as compared to the other two groups. Fasting PYY levels correlated negatively with fasting ghrelin levels and with ghrelin AUC and they were the only predictor for ghrelin AUC (beta = -0.464, P = 0.034). The increase in PYY correlated negatively with the decrease in ghrelin at times 60 min and 120 min in PWS.
CONCLUSIONS: In PWS, the low decrease in postprandial ghrelin levels could be related to the low fasting PYY concentrations and their blunted postprandial response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223988     DOI: 10.1111/j.1365-2265.2006.02707.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

Review 1.  The ghrelin/GOAT/GHS-R system and energy metabolism.

Authors:  Chung Thong Lim; Blerina Kola; Márta Korbonits
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

2.  Fasting plasma peptide YY concentrations are increased in patients with major depression who associate weight loss.

Authors:  O Giménez-Palop; R Coronas; J Cobo; L Gallart; J D Barbero; I Parra; G Fusté; J Vendrell; M Bueno; J M González-Clemente; A Caixàs
Journal:  J Endocrinol Invest       Date:  2011-12-15       Impact factor: 4.256

Review 3.  Neural and hormonal control of food hoarding.

Authors:  Timothy J Bartness; E Keen-Rhinehart; M J Dailey; B J Teubner
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-08       Impact factor: 3.619

Review 4.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

5.  Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.

Authors:  Pinar Gumus Balikcioglu; Metin Balikcioglu; Michael J Muehlbauer; Jonathan Q Purnell; David Broadhurst; Michael Freemark; Andrea M Haqq
Journal:  J Clin Endocrinol Metab       Date:  2015-08-10       Impact factor: 5.958

6.  Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.

Authors:  Andrea M Haqq; Michael Muehlbauer; Laura P Svetkey; Christopher B Newgard; Jonathan Q Purnell; Steven C Grambow; Michael S Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2007-07-30       Impact factor: 3.478

Review 7.  Structure and physiological actions of ghrelin.

Authors:  Christine Delporte
Journal:  Scientifica (Cairo)       Date:  2013-11-28

8.  Hedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion.

Authors:  A E Rigamonti; S Bini; F Piscitelli; A Lauritano; V Di Marzo; C Vanetti; F Agosti; A De Col; E Lucchetti; G Grugni; A Sartorio
Journal:  Food Nutr Res       Date:  2017-05-02       Impact factor: 3.894

9.  Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model.

Authors:  Juan A Rodriguez; Emily C Bruggeman; Bharath K Mani; Sherri Osborne-Lawrence; Caleb C Lord; Henry F Roseman; Hannah L Viroslav; Prasanna Vijayaraghavan; Nathan P Metzger; Deepali Gupta; Kripa Shankar; Claudio Pietra; Chen Liu; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

10.  Lack of Postprandial Peak in Brain-Derived Neurotrophic Factor in Adults with Prader-Willi Syndrome.

Authors:  Marta Bueno; Susanna Esteba-Castillo; Ramon Novell; Olga Giménez-Palop; Ramon Coronas; Elisabeth Gabau; Raquel Corripio; Neus Baena; Marina Viñas-Jornet; Míriam Guitart; David Torrents-Rodas; Joan Deus; Jesús Pujol; Mercedes Rigla; Assumpta Caixàs
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.